Occupational exposure to wood dust and risk of lung cancer: the ICARE study.


Journal

Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759

Informations de publication

Date de publication:
12 2019
Historique:
received: 08 03 2019
revised: 22 07 2019
accepted: 25 08 2019
pubmed: 21 9 2019
medline: 10 3 2020
entrez: 21 9 2019
Statut: ppublish

Résumé

In a previous analysis of data from a French population-based case-control study (the Investigation of occupational and environmental CAuses of REspiratory cancers (ICARE) study), 'having ever worked' in wood-related occupations was associated with excess lung cancer risk after adjusting for smoking but not for occupational factors. The present study aimed to investigate the relationship between lung cancer risk and wood dust exposure after adjusting for occupational exposures. Data were obtained from 2276 cases and 2780 controls on smoking habits and lifelong occupational history, using a standardised questionnaire with a job-specific questionnaire for wood dust exposure. Logistic regression models were used to calculate ORs and 95% CIs adjusted for age, area of residence, tobacco smoking, the number of job periods and exposure to silica, asbestos and diesel motor exhaust (DME). No significant association was found between lung cancer and wood dust exposure after adjustment for smoking, asbestos, silica and DME exposures. The risk of lung cancer was slightly increased among those who were exposed to wood dust more than 10 years, and had over 40 years since the first exposure. Our findings do not provide a strong support to the hypothesis that wood dust exposure is a risk factor for lung cancer. This study showed the importance of taking into account smoking and occupational coexposures in studies on lung cancer and wood dust exposure. Further studies evaluating the level and frequency of exposure during various tasks in woodwork are needed.

Identifiants

pubmed: 31537717
pii: oemed-2019-105802
doi: 10.1136/oemed-2019-105802
doi:

Substances chimiques

Dust 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

901-907

Investigateurs

Anne-Valérie Guizard (AV)
Arlette Danzon (A)
Anne-Sophie Woronoff (AS)
Velten Michel (V)
Antoine Buemi (A)
Émilie Marrer (É)
Brigitte Tretarre (B)
Marc Colonna (M)
Patricia Delafosse (P)
Paolo Bercelli (P)
Florence Molinie (F)
Simona Bara (S)
Benedicte Lapotre-Ledoux (B)
Nicole Raverdy (N)
Oumar Gaye (O)
Farida Lamkarkach (F)
Corinne Pilorget (C)

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Mireille Matrat (M)

Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, U1018, Equipe Epidemiologie des Cancers, Gènes et Environnement, INSERM, Villejuif, France mireille.matrat@inserm.fr.
Faculty of Medicine IFR 10, University Paris-Est Créteil, Créteil, France.

Loredana Radoï (L)

Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, U1018, Equipe Epidemiologie des Cancers, Gènes et Environnement, INSERM, Villejuif, France.
Faculty of Dental Surgery, University Paris Descartes, Paris, France.

Joëlle Févotte (J)

Unité Mixte de Recherche Epidémiologique et de Surveillance Transport Travail Environnement (UMRESTTE), Université Claude Bernard Lyon 1, Lyon, France.

Florence Guida (F)

Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, U1018, Equipe Epidemiologie des Cancers, Gènes et Environnement, INSERM, Villejuif, France.

Sylvie Cénée (S)

Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, U1018, Equipe Epidemiologie des Cancers, Gènes et Environnement, INSERM, Villejuif, France.

Diane Cyr (D)

Population-Based Epidemiological Cohorts Unit (UMS 011) INSERM-UVSQ, INSERM, Villejuif, France.
UMS 011, University of Versailles St-Quentin, Villejuif, France.

Marie Sanchez (M)

Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, U1018, Equipe Epidemiologie des Cancers, Gènes et Environnement, INSERM, Villejuif, France.

Gwenn Menvielle (G)

Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP, UMR1136), Sorbonne Universités, INSERM, Paris, France.

Annie Schmaus (A)

Population-Based Epidemiological Cohorts Unit (UMS 011) INSERM-UVSQ, INSERM, Villejuif, France.
UMS 011, University of Versailles St-Quentin, Villejuif, France.

Emilie Marrer (E)

Registre des tumeurs du Haut Rhin, Centre Hospitalier de Mulhouse ARER 68, Mulhouse, France.

Danièle Luce (D)

UMRS 1085 IRSET, INSERM, Pointe-à-Pitre, France.
Campus de Fouillole, University of Rennes 1, Pointe à Pitre, France.

Isabelle Stücker (I)

Université Paris-Saclay, Université Paris-Sud, UVSQ, CESP, U1018, Equipe Epidemiologie des Cancers, Gènes et Environnement, INSERM, Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH